Perrigo chewses smoking cessation
This article was originally published in The Tan Sheet
Perrigo receives ANDA generic drug approvals for over-the-counter nicotine polacrilex gum in 2mg and 4 mg doses Sept. 16. The approvals total six, with regular, mint and orange flavors for each dose. The approvals build on the firm's existing smoking cessation portfolio of nicotine replacement patch products (1"The Tan Sheet" Nov. 15, 1999, p. 13)....
You may also be interested in...
Watson does not expect an ongoing sales lag as a result of Perrigo's recent entry into the generic nicotine gum market
The introduction of Perrigo's private label nicotine transdermal system helped the firm post strong sales and earnings growth for the first quarter ended Oct. 2, the company announced Nov. 9.
The independent, family-controlled German group has signed a third R&D pact with Danish biotech Gubra to develop poly-agonist peptides for obesity.